Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | Q2730P |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | ATM Q2730P lies within the PI3K/PI4K domain of the Atm protein (UniProt.org). Q2730P results in decreased protein expression, loss of phosphorylation of Atm and downstream targets, and failure to form foci in response to irradiation in culture (PMID: 19431188). |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM Q2730P |
Transcript | NM_000051.4 |
gDNA | chr11:g.108335882A>C |
cDNA | c.8189A>C |
Protein | p.Q2730P |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011542843 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108335882A>C | c.8189A>C | p.Q2730P | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|